AKT1 and medulloblastoma: Although the contribution of JPO2 and LEDGF/p75 to medulloblastoma chemoresistance was not explored in these studies, both proteins were implicated as novel modulators of the c-MYC/PI3K/AKT signaling axis involved in medulloblastoma aggressiveness and metastasis.